Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
VTAK
2926
DELISTED
Catheter Precision
VTAK
| $427K | ﹤0.01% |
+4
| New | +$770K |
2020 Q2
0 quarters
|
|
2927
Vanguard Long-Term Treasury ETF
VGLT
$10B
| $420K | ﹤0.01% |
4,200
-3,100
| -42% | -$312K |
2020 Q1
1 quarter
|
|
|
HSTO
2928
DELISTED
Histogen Inc. Common Stock
HSTO
| $416K | ﹤0.01% |
5,457
+4,262
| +357% | +$358K |
2019 Q4
2 quarters
|
|
2929
Hallador Energy
HNRG
$656M
| $415K | ﹤0.01% |
633,033
+87,777
| +16% | +$67.6K |
2016 Q2
16 quarters
|
|
|
AXIA.PR
2930
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
| $408K | ﹤0.01% |
88,020
-27,909
| -24% | -$117K |
2019 Q1
5 quarters
|
|
2931
Intrepid Potash
IPI
$437M
| $406K | ﹤0.01% |
40,970
+2,310
| +6% | +$24K |
2019 Q4
2 quarters
|
|
|
BWIN
2932
Baldwin Insurance Group
BWIN
$3.09B
| $406K | ﹤0.01% |
+23,500
| New | +$284K |
2020 Q2
0 quarters
|
|
2933
Universal Logistics Holdings
ULH
$457M
| $405K | ﹤0.01% |
23,300
-1,200
| -5% | -$17K |
2020 Q1
1 quarter
|
|
2934
Energy Focus
EFOI
$19M
| $404K | ﹤0.01% |
+8,340
| New | +$213K |
2020 Q2
0 quarters
|
|
2935
FreightCar America
RAIL
$205M
| $403K | ﹤0.01% |
325,329
-5,537
| -2% | -$7.12K |
2017 Q2
12 quarters
|
|
2936
ImmunityBio
IBRX
$11.1B
| $402K | ﹤0.01% |
32,745
-1,657,218
| -98% | -$9.36M |
2016 Q4
14 quarters
|
|
2937
Direxion Daily Semiconductor Bear 3X ETF
SOXS
$1.89B
| – | – |
0
| – | – |
2020 Q2
0 quarters
|
|
|
AGRX
2938
DELISTED
Agile Therapeutics
AGRX
| $401K | ﹤0.01% |
72
-424
| -85% | -$2.2M |
2017 Q3
11 quarters
|
|
2939
Value Line
VALU
$412M
| $399K | ﹤0.01% |
14,800
-2,100
| -12% | -$60.1K |
2014 Q4
22 quarters
|
|
2940
Beam Global
BEEM
$24.2M
| $398K | ﹤0.01% |
39,900
-1,300
| -3% | -$10.1K |
2020 Q1
1 quarter
|
|
2941
CVD Equipment Corp
CVV
$29.1M
| $398K | ﹤0.01% |
129,292
+3,601
| +3% | +$11.5K |
2015 Q2
20 quarters
|
|
2942
Lipocine
LPCN
$14.2M
| $398K | ﹤0.01% |
18,594
+2,411
| +15% | +$31.2K |
2018 Q1
9 quarters
|
|
2943
Quest Resource Holding
QRHC
$29.1M
| $396K | ﹤0.01% |
293,229
+20,099
| +7% | +$26.6K |
2015 Q3
19 quarters
|
|
2944
Solana Company
HSDT
$156M
| $395K | ﹤0.01% |
+1
| New | +$574K |
2019 Q3
3 quarters
|
|
|
OIG
2945
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
| $395K | ﹤0.01% |
15,933
+85
| +0.5% | +$2.51K |
2017 Q2
12 quarters
|
|
|
CCM
2946
Concord Medical Services
CCM
$16.8M
| $391K | ﹤0.01% |
23,690
+60
| +0.3% | +$974 |
2013 Q2
28 quarters
|
|
|
ASFI
2947
DELISTED
Asta Funding Inc
ASFI
| $391K | ﹤0.01% |
30,252
+6,539
| +28% | +$73.5K |
2019 Q2
4 quarters
|
|
2948
Zedge
ZDGE
$46M
| $390K | ﹤0.01% |
263,573
+16,859
| +7% | +$18.9K |
2016 Q2
16 quarters
|
|
2949
BayCom
BCML
$333M
| $389K | ﹤0.01% |
30,100
+19,700
| +189% | +$244K |
2019 Q4
2 quarters
|
|
|
HBP
2950
DELISTED
Huttig Building Products, Inc.
HBP
| $388K | ﹤0.01% |
343,049
+23,711
| +7% | +$27K |
2014 Q1
25 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.